This paper explores how errors in the age-related epigenomes cause gene mutations, stem-cell exhaustion and malignant transformations, contributing to the development of cancer. It investigates emerging technologies, such as CRISPR-based epigenome editing, and their potential to reduce cancer risk before it begins.